These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19008810)

  • 1. [Immunocorrection in the treatment of diffuse peritonitis in aged patients].
    Briskin BS; Khachatrian NN; Peters GE; Kasat'ian GS; Fesenko TA
    Khirurgiia (Mosk); 2008; (10):19-26. PubMed ID: 19008810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined detoxification and immunocorrective therapy in patients with peritonitis].
    Shkrob LO; Fedotov PA; Ermakova NG
    Khirurgiia (Mosk); 1994 Mar; (3):20-2. PubMed ID: 8007606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urgent immunocorrection in crush syndrome].
    Karlov VA; Belotskiĭ ; Gutsu EV; Filiukova OB; Dikovskaia ES; Kuznetsov VP; Zueva VS; Abul'khanov AR; Lukoianova TN; Shkrob LO
    Ross Med Zh; 1992; (5-12):45-8. PubMed ID: 1286272
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endovascular surgery and the validation of immunocorrection in patients with liver cirrhosis complicated by portal hypertension].
    Karimov ShI; Kim VF; Iunusov IR
    Vestn Khir Im I I Grek; 1991 May; 146(5):26-8. PubMed ID: 1668432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary autoimmune syndrome and immunomodulating lymphotropic therapy in acute pancreatitis].
    Zaĭrat'iants OV; Kolobov SV; Iarema IV; Shevchenko VP
    Arkh Patol; 2002; 64(6):51-6. PubMed ID: 12534231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics and clinical use of immunostimulants].
    Shirinskiĭ VS; Zhuk EA
    Ter Arkh; 1990; 62(12):125-32. PubMed ID: 1707558
    [No Abstract]   [Full Text] [Related]  

  • 8. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
    Shafer NP
    Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin].
    Sarkisian SV
    Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current aspects and prospects of the combined treatment of respiratory papillomatosis in children].
    Zenger VG; Ashurov ZM; Selin VN; Shevtsov VV; Vozhagov VV
    Vestn Otorinolaringol; 1996; (4):19-21. PubMed ID: 8966871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of tactivin in the combined treatment and prevention of complications in reconstructive operations on the bones of the facial skeleton].
    Volozhin AI; Sazhina TG; Chergeshtov IuI; Arion VIa; Panin MG; Shipkova TP
    Stomatologiia (Mosk); 1996; 75(2):46-8. PubMed ID: 8754541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of tactivin and imunofan for the treatment of patients with endometrial carcinoma].
    Venediktova MG
    Eksp Klin Farmakol; 2001; 64(5):46-9. PubMed ID: 11764501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of thymus gland peptides in chronic cholecystitis].
    Rodoman GV; Belousov IuB; Kostrova MV; Petrov OA
    Sov Med; 1991; (3):73-4. PubMed ID: 1882302
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of treating patients with disseminated forms of destructive pulmonary tuberculosis using chemical preparations and T-activin].
    Chukanov VI; Gergert VIa; Khomenko IS
    Probl Tuberk; 1989; (6):30-3. PubMed ID: 2771908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
    Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
    Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of taktivin in postoperative intensive therapy in oncology].
    Gadalov VP; Arion VIa; Zhogoleva IB; Popova SR; Sviridova SP
    Vestn Akad Med Nauk SSSR; 1988; (9):68-73. PubMed ID: 3201821
    [No Abstract]   [Full Text] [Related]  

  • 18. [The electrophoretic mobility of peripheral blood lymphocytes in patients with tuberculosis of the lungs].
    Skvortsova RG; Nikitina OI
    Probl Tuberk; 1990; (5):11-4. PubMed ID: 2388887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunomodulators in the complex therapy of newborn infants with suppurative surgical infections].
    Samsygin SA; Dolgina EN; Arion VIa; Romanova LA; Shchevochkina GI
    Khirurgiia (Mosk); 1988 Jul; (7):101-6. PubMed ID: 3184700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.